Back to Search

FARRELL JOHNSON, MD

MD

Health Maintenance Organization

NPI: 1518062207Individual

Specialties, Licenses & Credentials

Health Maintenance OrganizationPrimary

Health Maintenance Organization

Code: 302R00000X

L4009(TX)

Research & Publications (20)

Abrogation of signal transducer and activator of transcription 3 reactivation after Src kinase inhibition results in synergistic antitumor effects.
PMID 17634553·Clin Cancer Res·2007
8-other
SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy.
PMID 18045060·Anticancer Agents Med Chem·2007
6-review
Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma.
PMID 16342249·Cancer·2006
3-trial
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
PMID 16203784·Clin Cancer Res·2005
8-other
A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
PMID 16199307·Int J Radiat Oncol Biol Phys·2005
3-trial
Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
PMID 15887238·J Cell Physiol·2005
8-other
Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylate.
PMID 15844661·J Exp Ther Oncol·2004
8-other
A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status.
PMID 14983495·Cancer·2004
3-trial
Dose-dense therapy with a novel irinotecan regimen for small-cell lung cancer.
PMID 12886869·Oncology (Williston Park)·2003
3-trial
Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
PMID 14596703·Clin Lung Cancer·2003
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
12575 TOULOUSE ST
HOUSTON, TX 77015

Quick Facts

NPI
1518062207
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile